SCHEMBL3985319

SCHEMBL3985319

CC(C)(O)C#Cc1ccccc1CNCCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MPO P05164 4/20 0.52
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
FDPS P14324 1/20 0.42
BCHE P06276 2/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.40
KCNA5 P22460 1/20 0.40
ATM Q13315 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC6A5 Q9Y345 3/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986252 0.78 HTT (0.47) MPOGAAMAPTBCHEKMT2A
SCHEMBL3991056 0.77 GAA (0.47) MPOGAAMAPTBCHEKMT2A
SCHEMBL3981107 0.75 MPO (0.58) MPOGAAMAPTBCHEKMT2A
SCHEMBL3737541 0.73 MEN1 (0.43) KMT2AMEN1ALDH1A1CYP3A4CYP2D6
SCHEMBL22980024 0.70 MPO (1.00) MPOGAAMAPTKDM4ECYP2D6
SCHEMBL23269544 0.67 EGFR (0.43) KMT2AMEN1ALDH1A1KDM4ECYP3A4
SCHEMBL3985527 0.66 MPO (0.64) MPOGAAMAPTBCHEKMT2A
SCHEMBL4478781 0.66 FDPS (0.61) GAAMAPTFDPSATM
SCHEMBL27228 0.66 GAA (0.95) MPOGAAMAPTBCHEKMT2A
SCHEMBL3985318 0.66 TSHR (0.45) MAPTKMT2AMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061449-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES Leo Pharma A/S (DK) 2009-05-27 EP claimed
WO-2008019690-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2008-02-21 WO claimed